Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2018.01.085
Abstract: BACKGROUND Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors (SGLT-2i) had lower rates of death and heart failure (HF). Whether the benefits of SGLT-2i vary based upon the presence of cardiovascular disease (CVD) is…
read more here.
Keywords:
risk;
death;
sglt;
cvd real ... See more keywords